Additional file 12: of Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancer

Table S1. Clinical demographics of treatment-naĂŻve (including both chemotherapy and immunotherapy) epithelial ovarian cancer patients at the time of primary debulking surgery. Patient identification number, age at diagnosis, tumor histologic type, FIGO stage, debulking status, residual tumor mass after debulking surgery, number of recurrences after primary debulking surgery, and RECIST to frontline chemotherapy after primary debulking surgery. (XLSX 10 kb)